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“The scale of our goals is lofty, 
but they are grounded in real 
and pressing challenges faced 
by our society—the need for 
greater knowledge and  
continued innovation.”
Gene E. Robinson
DIRECTOR, CARL R. WOESE 
INSTITUTE FOR GENOMIC BIOLOGY
TEN YEARS IN AND STILL CLIMBING
“The opportunity to position the Urbana campus 
as a major center for genomic biology turns on the 
linchpin of the PGI.”
-Carl Woese, in a 2003 letter to university officials to voice support 
for construction of the Post Genomic Institute (PGI), which would 
eventually become the Carl R. Woese Institute for Genomic Biology. 
Anniversaries can be a time for reflection and for inspiration. This year is the 
10th anniversary of the establishment of the Carl R. Woese Institute for Genomic 
Biology (IGB), an exciting milestone for the Institute; our panoply of celebratory 
events this year have provided many opportunities to evaluate our progress and 
our goals. In particular, this is a natural time for us to assess how well the IGB 
has lived up to the vision that led to its formation, and what our own vision is for 
the coming years.
The ideas that grew into the physical reality of the IGB were far-reaching ones. 
With the first major scientific advances of the genomic era came a recognition 
that the new field was one in which the University of Illinois could excel if the 
various strands of related research on campus could be unified by a common 
mission or shared space. By enabling the establishment of the IGB, funding from 
the state of Illinois made all three possible and promised to help position the 
university as a leader in biotechnological research.
Today, we can say with confidence that the IGB has lived up to that early promise, 
thanks to the faculty, students and staff who have worked to make it a truly 
transdisciplinary environment. So far, our adaptive system of faculty-proposed 
themes has ensured that our research portfolio remains cutting-edge. Our 
community of researchers is vibrant, collaborative, and diverse. The scale of our 
goals is lofty, but they are grounded in real and pressing challenges faced by our 
society—the need for greater knowledge and continued innovation.
This connection to the larger community is another central element of IGB’s 
mission. We were conceived as an institution positioned “where science meets 
society,” with an emphasis placed on fostering true dialogue between scientific 
researchers and the general public. A highlight of our 10th anniversary 
celebrations occurred in May, when we had the privilege of sharing the science 
of genomes at the Field Museum of Natural History in Chicago during a three-
day visit that spanned two Members’ Nights and visits by over 10,000 museum-
goers. The enthusiasm for science that permeated the event was an inspiration 
for presenters and attendees alike.
In this issue of Biomarker, we have shared a few highlights from this year’s 
festivities, as well as our traditional selection of exciting research developments. 
When we consider what is now possible—engineering cellular environments to 
foster stem cell development, developing effective and efficient genome-editing 
strategies for diverse organisms and a multitude of potential uses, creating new 
yeast strains to revolutionize the biofuel production process—we appreciate the 
consistent progress of genomic research, and see even grander possibilities in 
its future.
As we conclude our year, the future promise of our work is what matters most. 
The true spirit of the original vision for the IGB lies not only in metrics, but in 
our ability to continue to adapt and innovate. We take pride in how far we have 
come already, but even more in how our work has led to new goals set and new 
challenges undertaken. The power of the genomic approach still has much more 
to offer, and so do we.
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A decade of IGB 
inspires growth and 
discovery
It was the dawn of the genomic area. The Human Genome Project would 
confirm that the human genome contains over 20,000 genes, opening up 
a world of possibilities. 
Plans for the IGB had been laid, but state budgetary concerns had brought 
the construction schedule to a halt. Woese decided to write a letter to James 
Stukel, who was then the president of the University of Illinois, to voice 
his concern. 
“I have been a member of the University of Illinois faculty for 40 years. 
Never once in this time have I contacted the President of the University 
or members of the higher administration regarding matters of University 
policy,” he wrote. “Please, then, take the fact that I now address you on 
such an issue as a measure of the extreme importance I assign it.” 
Woese emphasized the IGB’s potential to make the 
University of Illinois campus “a major center for 
genomic biology” that would stimulate the bio-based 
economy in central Illinois. 
“The community, the campus and many of the faculty 
are looking to the [IGB] to provide the infrastructure 
that will enable development of new technologies 
that can be licensed to local business or faculty start-
up companies,” Woese continued. “If we fail in this 
mission, we will fail the people of the state and put 
ourselves at a decisive disadvantage in recruiting the 
best young scientific minds.”       
Four years and two days after Woese wrote this letter, the IGB was officially 
dedicated on March 29, 2007. 
But the IGB wasn’t always the institute that it is today. Ten years ago, it was 
built from the ground up by a team that included Jennifer Quirk, who has 
been with the IGB since it began and is now its Associate Director. 
“It was pretty fun when it was new,” Quirk said. “There were so few people 
doing things that everything seemed sort of monumental.” 
With Harris Lewin, the founding director of the IGB, Quirk played a part 
in creating a staff and figuring out what worked and what did not work for 
the institute’s unique structure. 
“In the beginning I built up the staff and it was all new,” she said. “Now it’s 
basically a mature building and a mature institute.” 
Over time, Quirk has seen the IGB gain faculty members who are now 
tackling large-scale research problems.
“We attract the best and brightest faculty on the campus because they want 
to come here and work on the unique problems we’re working on here,” 
she said. “So we attract the best and brightest faculty, which in turn, I 
would argue, attract the best and brightest students and postdocs.”
Quirk has always felt that the faculty’s dedication to the mission of the IGB 
has made a difference. 
“They want what’s best for the institution, not what’s best for them 
personally,” she said. 
She believes this is also true of the IGB’s administrative staff. 
“I really do think that we have the best administrative support staff on 
campus,” Quirk said. “We have this incredible staff that’s committed to 
the place.” 
Together, she sees the faculty and staff of the IGB as creating an 
environment that inspires innovative research. 
A decade after IGB began, the building now houses 
11 research themes that address challenges in 
environmental conservation, food security, energy, 
health, and technology. The newest themes are 
discovering new anticancer drugs and working to 
better understand infection biology. 
Recent research from the IGB has modified 
photosynthesis to increase crop yield, identified 
important mechanisms in bacteria, given us a 
look into our molecular heritage, and much more. 
“Our faculty, research staff and students are 
changing the world by using genomics in many 
different ways to tackle some of the most pressing 
grand challenges in fundamental and applied science,” said IGB Director 
and Swanlund Professor of Entomology,  Gene Robinson. “Fueling this, 
our cutting-edge research has secured some of the most prestigious and 
largest grants the campus has ever seen.” 
Recently, the IGB-affiliated Realizing Increased Photosynthetic Efficiency 
research project received a $45 million reinvestment from the Bill & 
Melinda Gates Foundation, the Foundation for Food and Agriculture 
Research, and the U.K. Department for International Development. 
The DOE also recently funded the $115 million Center for Advanced 
Bioenergy and Bioproducts Innovation, a collaboration between the IGB 
and the Institute for Sustainability, Energy, and Environment. 
“We’re delighted to be celebrating our 10th anniversary and look forward 
to many more years of path-breaking, genome-powered team science.” 
Robinson said. “Genomic technology changes so rapidly, we can only 
imagine the array of new tools that will be available to accomplish these 
goals, and we look to the future with great anticipation.” 
IN 2003, THE IGB’S FUTURE NAMESAKE, CARL WOESE, COULD ALREADY SEE HOW THE 
creation of the IGB would impact genomic research. 
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World of Genomics 
brings IGB research 
to Chicago
With six learning stations distributed across Stanley Field Hall, the 
main floor of the museum where famous T. rex Sue is displayed, 
World of Genomics represented the full scope of IGB research in 
health, technology, and the environment, with hands-on activities and 
exhibits for all ages.
The scale and scope of the event was made possible by numerous 
partners and sponsors, including Abbott, AbbVie, ZEISS Microscopy, 
Elanco, the Illinois Soybean Association Checkoff 
Program, NASA, Opentrons Pacific Biosciences, and 
the University of Illinois Sesquicentennial celebration. 
“In all of the outreach events I’ve been a part of, I’ve 
never experienced such an engaged audience that 
asked so many excellent, relevant questions about 
our research,” said Beryl Jones, one of the over 60 
volunteers from the IGB who staffed the event. “World 
of Genomics was truly one of the most rewarding 
experiences of my PhD, and I feel honored to have 
been a part of an event that reached so many people.”
Jones was one of the volunteers tasked with running the Brains and 
Behavior learning station, which focused on the shared genomic 
underpinnings of behavior between humans, honey bees, and other 
animals. To bring their work to life, researchers presented explorable 
brain models in virtual reality as well as an observation hive with live bees.
“It was an amazing experience,” said Michelle Goettge. She was a 
volunteer with the DNA to Drugs learning station, which presented 
information and activities based on antibiotic resistance, the 
development of new therapeutics, and high-throughput screening. 
“I’ve done outreach before, but it usually focuses on just one group—
kids or adults. World of Genomics really engaged with everyone, and 
people were so excited to learn about the science, it was unbelievable.”
Other learning stations included Food and Fuel, where visitors could 
control a miniature agricultural robot through plants demonstrating 
different phenotypic traits while the larger TERRA-MEPP rover looked 
on, and Personalized Health, which presented a suite of activities 
demonstrating differences between bodies of individuals as well 
as their commensal microbial communities to explain concepts in 
human health and development.
A fifth station, the sprawling Emergence of Life, partnered with ZEISS 
to bring high-end microscopy to the Field. There, visitors viewed the 
intricacies of coral and travertine at the nanoscale; remote microscopy 
from IGB Core Facilities scanning electron microscope was also on 
hand to image human kidney stones at an even higher resolution. 
ZEISS also provided several other instruments to other stations, 
offering a closer look at a variety of biological specimens.
In all, the event represented IGB’s largest 
outreach effort to date, and perhaps its most 
successful,   not only in the number of people 
reached, but in the quality of the interactions 
between scientists and guests.
Members’ Nights attendees responded with 
high praise, with comments such as “The World 
of Genomics was absolutely amazing,” “Loved 
the virtual reality experience by the bees,” 
and “More research information booths like 
U of I. Those were amazing.” The volunteers 
especially made a lasting impression, with responses including “The 
U of I people explaining the exhibits were all very enthusiastic, patient, 
and knowledgeable.”
One attendee elaborated, “I enjoyed the exhibits by the university 
students. First of all, they were interesting. Even more importantly, they 
gave us a vision of the future—the next generation of scientists.” When 
asked for favorites, attendees responded “Crop robot and talk on GMO 
vs other, viewing the 3D printer, virtual reality” and, simply, “Bees.”
“We reached everyone from young children to their grandparents, 
from those who had never heard of us to Chicago alumni, friends of 
the university, even the University of Illinois President,” IGB Director 
and Swanlund Professor of Entomology Gene Robinson said of the 
event. “The entire floor was abuzz with rapt and engaged visitors, who 
immersed themselves into each exhibit, learning about our research, 
talking to our people, and gaining a new understanding of how 
fundamental genomics is to their lives.”
FROM MAY 18TH TO 20TH, 2017 IN CHICAGO, OVER 10,000 VISITORS EXPERIENCED 
the World of Genomics at the Field Museum of Natural History, a three-day event presented by the 
IGB. A large, blue-lit funnel presented an artistic interpretation of the tree of life; beneath it, the 
world’s smallest sequencer read out the genomes of never-before-sequenced organisms.
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A recent study, reported in the Proceedings of 
the National Academy of Sciences, has yielded 
new insights into the parallels between bees 
and humans who are less responsive to 
certain social stimuli. Researchers found that 
some genes associated with autism spectrum 
disorders in humans are regulated differently 
in less responsive honey bees than in their 
more responsive nest mates.
The study yielded a new view of the molecular 
heritage shared across animals, the research-
ers said, and offered tantalizing clues about 
the evolution of social behavior.
“Some honey bees are more active than 
others, and some appear indifferent to 
intruders that threaten the hive. This, in 
itself, is not unusual,” said IGB Director and 
Swanlund Professor of Entomology Gene 
Robinson, who led the project. “Honey bees 
take on different roles at different stages of 
their lifecycle, and not every bee can—or 
should—function as a guard,” he said.
But when postdoctoral researcher Hagai 
Shpigler observed that some of those same 
bees also were unmoved by the presence of 
a queen larva—a stimulus that typically spurs 
diligent action in bees involved in caring for 
young in the hive—it suggested something 
unusual was going on, said Robinson.  
“For any given task, most honey bees 
fall somewhere in the highly engaged to 
moderately engaged camp,” Robinson said. 
“Typically, honey bees will respond more 
robustly to one stimulus than to another.” A 
few bees, though, responded to neither type 
of stimulus examined in the study.
To explore the biological mechanisms that 
might drive this behavioral variation, the 
team analyzed 246 groups of bees from 
seven genetically distinct honey bee colonies, 
carefully testing each bee in various social 
contexts, then analyzing levels of gene 
expression in their brains. They found 
that more than 1,000 genes were regulated 
differently between less responsive bees, 
nurse bees, and guards.
The researchers found a significant overlap 
between the less responsive honey bees’ gene 
expression profile and genes associated with 
autism in humans. Further analyses found 
no significant overlap with human genes 
associated with depression, schizophrenia or 
several other mental disorders.
“Our data are telling us that social 
unresponsiveness does have some common 
molecular characteristics in these distantly 
related species,” Robinson said.
“It’s important to point out some caveats,” he 
said. “Humans are not big bees and bees are 
not little humans. The social responsiveness 
depends on context, and is different in the 
two cases. Autism spectrum disorder is very 
complex, and unresponsiveness is not the 
only behavior associated with it.”
While social behavior likely evolved 
independently in honey bees and humans, 
Robinson said, “our data reveal that they 
make use of common toolkits, common 
building blocks.”
The Simons Foundation and the NSF 
supported this research.
Study finds parallels in variation in  social responsiveness in bees & humans
HUMANS AND HONEY BEES ARE BOTH SOCIAL CREATURES, AND BOTH 
have evolved to respond strongly to social cues—the threat of an intruder, the hunger of a relative in 
need, the appearance of a potential mate. Yet within communities of bees and people, individuals 
vary in how strongly they respond to each type of cue, or to social cues in general.
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FOR CELLS WITHIN THE HUMAN 
body, where you grow up influences 
who you become—physical character-
istics of different tissues will help new-
born cells follow the right developmen-
tal path. Chemical and biomolecular 
engineering professor Brendan Harley 
(RBTE Theme Leader) and colleagues 
have now reported they can alter blood 
cell development through the use of 
biomaterials that mimic characteristics 
of bone marrow.
The findings, reported in the journal Science 
Advances, are a first step toward developing 
more effective bone marrow treatments for 
diseases like leukemia and lymphoma. The 
NSF, NIH, and the American Cancer Society 
of Illinois supported this research.
Blood cells flow throughout the body 
delivering life-supporting oxygen and 
nutrients. As these cells age and die, new 
ones are generated by bone marrow, the 
soft tissue inside the body’s long and hollow 
bones.
Harley, who led the research with postdoctoral 
researcher Ji Sun Choi, explained that 
certain regions of bone marrow contain 
hematopoietic stem cells (HSCs), which are 
the parent cells of all blood and immune cells. 
“The tissue environment that surrounds 
these cells in the bone marrow provides a 
wealth of signals that can alter how these 
precursor cells behave. This paper looked 
at the signals provided by the tissue matrix 
itself,” said Harley.
One of the major treatments for leukemia 
and lymphoma involves transplanting HSCs. 
The donor stem cells must locate marrow 
cavities, then nestle there and start producing 
blood and immune cells. However, there is a 
limited quantity of available donor HSCs and 
the success rate of transplantation is low.
“We’re interested in this problem from an 
engineering standpoint,” Harley said. “The 
goal is to create better tools to both expand 
the number of donor HSCs and improve 




Like cells throughout the body, HSCs are 
contained in a three-dimensional tissue 
environment known as the extracellular matrix. 
Harley and Choi gathered samples of HSCs 
from mice and then grew them in the laboratory 
using biomaterials engineered to mimic some 
of the extracellular matrix properties of the 
native bone marrow. Their goal was to examine 
how these engineered systems could alter the 
HSCs’ capacity to proliferate and differentiate 
to become blood cells.
The researchers examined two main 
elements of the matrix that regularly interact 
with HSCs: collagen and fibronectin. They 
found that the HSCs that were exposed to 
collagen proliferated more rapidly, but that 
they had differentiated, meaning they were 
no longer stem cells. When exposed to 
fibronectin, they proliferated less rapidly but 
remained stem cells.
“With the collagen substrates, we got more 
cells but not useful cells,” Harley said. “With 
the right combination of stiffness in the 
matrix and the presence of fibronectin, we 
identified a class of biomaterials that show 
promise for being able to maintain and 
eventually expand these stem cells outside of 
the body. An engineered bone marrow will be 
of enormous value for treating hematopoietic 
cancers such as leukemia.”
Harley and other researchers in his lab are 
currently investigating other features of the 
matrix that can be manipulated to increase 
the number of stem cells and make them 
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The heart is a dynamic muscle whose cells 
have the ability to change size depending 
on the heart’s needs. A new study of mouse 
hearts reveals a previously unknown 
mechanism by which heart cells control 
their size by ramping up or stopping the 
production of a key protein called PABPC1. 
The findings, reported in the journal 
eLife, could assist in the development of 
therapeutics that promote healthy heart 
growth and prevent disease.
During exercise, the heart beats harder to 
pump oxygen to the muscles. Heart cells 
adapt over time by boosting production of 
specific proteins to increase in size, said 
biochemistry professor Auinash Kalsotra 
(GNDP/ONC-PM), who led the study with 
postdoctoral researcher Sandip Chorghade 
and graduate student Joseph Seimetz. 
In their NIH-supported study, the researchers 
focused on PABPC1, a protein that binds to 
RNA and helps translate RNA into proteins. 
Scientists had long assumed all cells needed 
PABPC1 to survive and make new proteins. 
But the researchers discovered that the 
protein is absent in the adult heart, though it 
is present in all human and mouse cells. 
This finding explains why heart cells produce 
significantly lower levels of new proteins 
than other tissues in the body—a fact that 
was known but not understood until now. 
“The finding that PABPC1 is usually not 
present in adult heart cells until needed for 
growth suggests that if you could control 
the function of this protein, then you could 




WHEN WE ARE CONFRONTED 
with the remarkable diversity and 
complexity of forms among living 
things—the lightweight and leathery 
wings of a bat, the dense networks of 
genes that work together to produce 
a functional cell—it can be hard to 
imagine how chance mutations and 
selective processes produced them. If 
we could rewind evolutionary time, 
what would we see?
In a new study published in Proceedings of 
the Royal Society B and funded by the NSF, 
Wellcome Trust, and Leverhulme Trust, 
animal scientists at Illinois, King’s College 
London, and the University of Chicago have 
made a discovery that was hidden in the 
development of opossums. They found one 
possible version of the evolutionary path that 
led from the simple ears of reptiles to the 
more elaborative and sensitive structures of 
mammals, including humans.
Three tiny bones in the middle ear of mammals 
form a mechanism that converts the air 
vibrations of sound into the electrical impulses 
understood by the brain. In the simpler ears of 
reptiles, as well as the shared ancestors of both 
groups, only one of these bones is found in the 
middle ear, while the other two form part of the 
jaw. This contrastdrew the attention of Associate 
Professor of Animal Biology Karen Sears (RBTE) 
and IGB Fellow Daniel Urban, who led the 
study and have since moved on to positions at 
University of California, Los Angeles.
“We came at this project through the approach 
of evolutionary developmental biology (evo-
devo), which looks at the development 
of an organism … to help understand its 
evolutionary history,” said Urban, explaining 
their experimental approach.
To get a better idea of how the mammalian ear 
might have evolved, Sears, Urban and their 
colleagues chose to study the gray short-tailed 
opossum, a small and charismatic South 
American marsupial whose key stages of jaw 
and ear development take place gradually and 
after birth.
The group first detailed the anatomical 
progression of middle ear development 
in their opossums, capturing images that 
revealed the changing architecture of cartilage 
and bone. They observed that the progression 
of structures in the developing opossum jaw 
and ear appeared to re-enact the evolutionary 









“It was truly remarkable how well the 
developmental stages of our extant opossum 
model organism matched up with the 
transitional fossils ... this makes our study 
organism, the gray short-tailed opossum, 
a fantastic living model to aid in the 
understanding of development of long extinct 
taxa,” Urban said. “By using this modern 
analogue, we can learn so much more about 
these earlier species and the origins of 
mammals.”
The team also explored changes in gene 
activity and individual cells that occurred 
during the cartilage breakdown process that 
allows mammalian ear bones to migrate 
to their final positions. They identified a 
set of genes whose increased activity was 
correlated with the self-destruction of the 
cells that connect the future jaw to the future 
ear. Among these genes, the researchers 
focused on a gene called TGF-β for further 
investigation.
When Urban and his colleagues treated 
developing opossums with a drug that blocks 
the signaling of the TGF-β protein, the death 
of cartilage cells was prevented and the 
ear bones remained a part of the jaw, their 
arrangement appearing to have slid backward 
through evolutionary time. This suggests 
that a chance mutation in a key gene could 
produce the same effect, providing a possible 
pathway by which the mammalian ear might 
have evolved.
By using this modern 
analogue, we can 
learn so much more 
about these earlier 






IN AN AGE OF BOOMING BIO- 
technology, we still rely on the bounty 
of the natural world. Microbes, rather 
than always making us sick, give us 
some of our best cures in the form of 
naturally occurring products such as 
penicillin and tetracycline.
Recently, “big data” genome technology has 
begun to help us discover nature’s inventions. 
A team of researchers led by Associate 
Professor of Chemistry Douglas Mitchell 
(MMG) has created a tool that searches 
through microbial genomes, identifying 
clusters of genes that indicate an organism’s 
ability to synthesize therapeutically promising 
molecules.
In a Nature Chemical Biology article, lead 
authors Jonathan Tietz and Christopher 
Schwalen and colleagues in Mitchell’s 
laboratory described how their custom 
software learns to recognize predictive 
genomic features.
Mitchell’s group is particularly interested 
in a class of molecules commonly referred 
to as RiPPs, a friendly acronym for a long 
name: ribosomally synthesized and post-
translationally modified peptides. RiPPs, like 
proteins, are made of chains of linked amino 
acids, are encoded by genes, and undergo 
chemical modification (carried out by other 
proteins) after they are made.
RiPPs may seem unfamiliar, but they are 
already present in the average consumer’s 
daily life. A bacterially-produced RiPP called 
nisin, for example, has been used as a 
pathogen-fighting additive in dairy products, 
meats, and beverages such as beer since the 
1960s.
Traditionally, researchers found potentially 
useful natural products by screening 
microbes based on their biological activity. 
After decades of such efforts, which revealed a 
range of products including some RiPPs, the 
low-hanging fruit has been plucked; searches 
turn up the same common compounds over 
and over again.
Mitchell and colleagues use genome mining, 
essentially skimming through cells’ recipe 
books to see what they might be able to 
produce, as a way to “climb higher” and find 
novel natural products, including RiPPs. 
To do this, the researchers needed to create 
software that could recognize the groups 
of genes whose products work together to 
synthesize a RiPP.
They decided to make it even tougher by 
focusing on a class of RiPPs called lasso 
peptides, named for their looping structure. 
The clusters of genes that produce lasso 
peptides are small and generic-looking, 
making them difficult to identify even in a 
manual search.
“If you want to show that you have a useful 
tool, you pick the hardest example,” Mitchell 
said. “But also, as a chemist, lasso peptides 
are extremely interesting” because they are so 
chemically robust.
The informatics tool that Mitchell’s laboratory 
designed, named RODEO (Rapid Open 
reading frame Description and Evaluation 
Online), was “trained” via machine learning 
on known examples of lasso-producing gene 
clusters, allowing the program to hone in on 
key features.
The resulting software robustly identified 
promising gene clusters in a broad array 
of microbial genomes, and could be easily 
customized to search for the gene clusters of 
other classes of RiPPs as well.
“We can now use genomic prioritization 
to find molecules that without any doubt 
are structurally novel,” said Mitchell. “The 
challenge is, is that a useful molecule or not? 
So that’s the next 10 years of discovery.”
This work was supported by the NIH, the 
American Chemical Society, the David and 
Lucile Packard Foundation, and Robert C. 
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The DOE is doubling down on energy 
research at Illinois, funding a multi-million 
dollar Bioenergy Research Center to provide 
scientific breakthroughs for a new generation 
of sustainable, cost-effective biofuels and 
bioproducts.
The DOE announced the $115 million Center 
for Advanced Bioenergy and Bioproducts 
Innovation (CABBI), pending Congressional 
appropriation, a collaboration between 
Illinois’ Institute for Sustainability, Energy, 
and Environment (iSEE) and the IGB. 
CABBI includes 16 partner institutions. Evan 
H. DeLucia, G. William Arends Professor 
of Plant Biology and Baum Family Director 
of iSEE (EBI/GEGC), will serve as CABBI 
Director.
“This grant is a game-changer, and CABBI 
will be at the forefront as we press toward a 
new bio-based economy,” DeLucia said. “Our 
Center’s holistic approach will generate new 
products directly from biomass, reducing 
our nation’s dependence on fossil fuels and 
making us more secure.”
One of the major challenges the world faces 
is providing sustainable sources of energy 
that meet societal needs as the population 
continues to grow. DeLucia said Illinois is 
uniquely qualified to address the challenge 
with a world-class facility at IGB.
CABBI researchers will develop fuels 
and products by integrating three highly 
interconnected DOE priority areas: growing 
the right crops, turning plants into fuel, 
and determining the environmental and 
economic bottom line. 
“We look forward to a day when we will have 
sustainable and economically sound pro-
duction of fuels and chemicals from plants,” 
DeLucia said. “A vibrant bioeconomy based 
on plant products will enhance the economic 
and ecological resilience of U.S. agriculture.”
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A STUDY OF THE DNA IN 
ancient skeletal remains adds 
to the evidence that indigenous 
groups living today in southern 
Alaska and the western coast of 
British Columbia are descendants 
of the first humans to make their 
home in northwest North America 
more than 10,000 years ago.
“Our analysis suggests that this is the same 
population living in this part of the world 
over time, so we have genetic continuity 
from 10,000 years ago to the present,” 
said Associate Professor of Anthropology 
Ripan Malhi (CGRH/RBTE), who led the 
study with collaborators from multiple 
institutions around the world.
The findings, reported in the Proceedings 
of the National Academy of Sciences, also 
suggest that these early American peoples 
had a complex population history. The 
work was supported by the University 
of Illinois; the Canadian Museum of 
History in Gatineau, Quebec, Canada; and 
Pennsylvania State University.
The new work comes on the heels of earlier 
studies of ancient Americans that focused 
on mitochondrial DNA, which occurs 
outside the nucleus of cells and is passed 
only from mothers to their offspring.
“Mitochondrial DNA just traces the 
maternal line—your mother’s mother’s 
lineage—so, you’re missing information 
about all of these other ancestors,” said 
John Lindo, a postdoctoral researcher at 
the University of Chicago and first author 
on the paper. “We wanted to analyze the 
nuclear genome so we could get a better 
assessment of the population history of 
this region.”
The team looked at genomic data from 
Shuká Káa (Tlingit for “Man Before Us”), 
an ancient individual whose remains 
date to about 10,300 years ago. They also 
analyzed the genomes of three more 









Left: Tsimshian artist David A. Boxley 
created the carved and painted cedar house 
front in the foyer of the Walter Soboleff 
Building, Sealaska Heritage’s headquarters 
in Juneau. Photo by Ken Graham
British Columbia whose remains date to 
between 6,075 and 1,750 years ago.
“Interestingly, the mitochondrial type that 
Shuká Káa belonged to was also observed 
from another ancient skeleton dated to about 
6,000 years ago,” said Brian Kemp, a coauthor 
and associate professor of anthropology 
at the University of Oklahoma. “It seems 
to disappear after that. The nuclear DNA 
suggests that this is probably not about 
population replacement, but rather chance 
occurrence through time.”
“The data suggest that there were multiple 
genetic lineages in the Americas from at least 
10,300 years ago,” Malhi said.
The descendants of some of those lineages 
are still living in the same region today, 
and a few are co-authors on the new study. 
Their participation is the result of a long-
term collaboration between the scientists 
and several native groups who are embracing 
genomic studies as a way to learn from their 
ancestors, said coauthor Rosita Worl, who is 
president of the Sealaska Heritage Institute. 
Worl is Tlingit, Ch’áak’ (Eagle) moiety of the 
Shangukeidí (Thunderbird) Clan from the 
Kawdliyaayi Hít (House Lowered From the 
Sun) in Klukwan, Alaska. 
“We supported DNA testing of Shuká Káa 
because we believed science ultimately would 
agree with what our oral traditions have 
always said—that we have lived in southeast 
Alaska since time immemorial. The initial 
analysis showed the young man was native, 
and now further studies are showing that our 
ancestral lineage stems from the first initial 
peopling of the region,” said Worl. “Science is 
corroborating our oral histories.”
We supported 
DNA testing 
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producing bacteria and 
colon cancer in  
African Americans
A NEW STUDY REVEALS THAT 
African-Americans have measurable 
differences in the number and type 
of bacteria that live in the colon—and 
those differences are related to their 
higher-than-average colon cancer risk.
The study, reported in the journal Gut, looked 
at colonic tissue biopsies from 197 African-
Americans and 132 non-Hispanic whites 
collected over a two-year period ending in 
2012. The researchers amplified microbial 
DNA from the samples, then looked at the 
abundance of various types of microbes.
The study found that African-Americans have 
more sulfide-producing bacteria in their colon 
than non-Hispanic whites in the U.S. do. 
Although these microbes are a normal part 
of the gut ecosystem, an overabundance of 
sulfide in the colon can lead to inflammation 
and can damage DNA, said animal sciences 
professor Rex Gaskins (RBTE), who led 
the new research with Nathan Ellis, the 
Faculty Director of the Genomics and 
DNA Sequencing Facilities in the Research 
Resources Center at the University of Illinois 
at Chicago at the time of the study. 
“We found that African-Americans have an 
increased abundance of bacteria that make 
hydrogen sulfide, which we demonstrated 
more than a decade ago to be a potent 
genotoxin,” Gaskins said.
The study also revealed that Bilophila 
wadsworthia, a bacterium that produces 
hydrogen sulfide from the amino acid 
taurine, was significantly more abundant in 
African-Americans with colon cancer than in 
their healthy counterparts.
“These bacteria are using nutrients associated 
with an animal-based diet,” Gaskins said.
The relationship between B. wadsworthia 
abundance and colon cancer risk did not hold 
true for non-Hispanic whites, however.
Most cases of colorectal cancer—about 85 
to 90 percent—are sporadic, rather than 
familial, Gaskins said. There may be a genetic 
element, but environmental factors like 
exposure to pollutants or dietary components 
also are required to spur the onset of cancer.
“You have to have a genotoxin to have colon 
cancer,” Gaskins said. “And sulfide is a genotoxin.”
African-Americans have significantly higher 
incidence of colon cancer than other Americans. 
In 2013, there were 33.5 colon cancer cases per 
100,000 African-Americans, compared with 
26.8 per 100,000 whites.
Explaining these disparities has not been 
easy. Native Africans have dramatically lower 
colon cancer rates than African-Americans, 
suggesting that environmental factors, 
including dietary habits, are a key to the 
problem, along with genetics. 
A 2014 study on which Gaskins was a senior 
co-author found that when rural South African 
Zulus, who normally ate a low-fat, high-fiber 
diet, switched to a diet with a lot of meat and 
animal fat, sulfide-producing bacteria in their 
colon increased. This change took less than 
two weeks, the researchers found.
Scientists already knew that a diet high in 
red meat and animal fat was associated with 
an increased risk of developing colon cancer, 
Gaskins said. 
“We are now beginning to connect the dots 
between these dietary factors and one’s risk 
of developing colon cancer risk,” he said. 
“Our research adds to the evidence that the 
microbes that inhabit the colon are part of the 
equation and should not be overlooked.”
The NIH and the American Cancer Society 
supported this research.
Left: Bilophila wadsworthia, a bacterium correlated with colon cancer in African-American patients
Our research adds to the 
evidence that the microbes that 
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mechanism in unusual 
species of trap-jaw ant
Pictured: Ant from the genus Myrmoteras. 
Photo by Steve Shattuck
RESEARCHERS REVEALED HOW A 
group of trap-jaw ants can snap their 
jaws shut at speeds of up to 50 miles 
per hour—just fast enough to capture 
their elusive prey.
They reported their findings in the Journal of 
Experimental Biology.
The ants belong to the genus Myrmoteras, 
and are one of four groups of ants that have 
independently evolved the ability to quickly 
snap their powerful jaws shut to capture speedy 
prey. They feed primarily on springtails, tiny 
arthropods that fling themselves away from 
danger when they detect a threat. Myrmoteras 
ants hold their jaws open at a 280-degree 
angle until they encounter their prey and snap 
their jaws shut on their target in a fraction of 
a second.
“These ants are rarely seen in nature and 
almost impossible to keep alive in the lab,” 
said Associate Professor of Animal Biology 
and Entomology Andrew Suarez (GNDP), 
who led the study with former graduate 
student Frederick Larabee, now a postdoctoral 
researcher at the Smithsonian Institution’s 
National Museum of Natural History.
“Each group of trap-jaw ants has a different way 
to store and release energy. Working with this 
genus has been sort of a holy grail for us,” Suarez 
said. “Studying these ants gives us insight into 
solutions for real-world issues related to energy 
storage and high-speed systems.”
The jaws of Myrmoteras ants can snap shut 
in half a millisecond, much faster than the 
human eye can perceive. Such speed cannot 
be attained by muscle strength alone. Animals 
whose movements exceed this limitation, 
including trap-jaw ants, do so through 
anatomical adaptations—evolved body parts 
that act like springs or latches to enhance the 
motions produced by muscles.
To visualize the ants’ jaws and understand 
what mechanism allows them to break 
the muscular speed limit, Larabee used a 
microscope and microcomputed tomography, 
which exposes tiny specimens to X-rays 
to discern their internal structures. His 
observations allowed him to determine how 
the jaws likely work.
Larabee detected a feature of the ant’s 
mandible that allow it to lock its jaws open. 
Just before a strike, a lobe on the back of 
the ant’s head compresses. A trigger muscle 
releases the jaws, executing the strike.
“What’s interesting is that the arrangement of 
the muscles and how the jaws are locked open 
are completely different from other trap-jaw 
ants that have been studied,” Larabee said. “It 
seems like it’s a completely unique evolution 
of this system.”
However, the jaws of the Myrmoteras ants are 
only as fast as they need to be, Larabee said. 
While the peak velocity achieved by their jaws 
is comparable to that of other trap-jaw ants, 
their acceleration is considerably slower. The 
researcher hypothesized that the resulting lag 
may not make much difference in the ants’ 
ability to capture prey: the springtails they eat 
take 10-50 milliseconds to effect an escape 
once they detect an attack, which leaves 
Myrmoteras enough time to snatch the soft 
springtail bodies in their knife-like jaws.
“They just need to be faster than the critters 
they’re trying to eat, and their jaws are plenty 
fast for capturing springtails,” he said.
The NSF, the Smithsonian Institution and 

















these studies] of this corn is required to be 
mixed with conventional dent corn,” Singh 
said. “The superior yeast provides the second 
enzyme, glucoamylase, and also provides 
an alternate metabolic pathway to reduce 
byproduct formation during fermentation. 
Combined use of this corn and superior yeast 
can reduce the total enzyme addition by more 
than 80 percent.”
Another approach to improve the dry grind 
process is to use high solids in the plant. 
However, according to Singh, high solid 
concentrations lead to high ethanol build-up 
in the tank. 
“High ethanol affects the yeast viability and 
inhibits its fermentation performance, so 
we have added a third technology to the 
process. We remove the ethanol as it is 
being produced, using a vacuum flashing 
process that is patented technology from 
the University of Illinois,” Singh said. “Only 
a couple of vacuum cycles of 1 to 1.5 hours 
can bring the ethanol concentration below 
the inhibitory levels without affecting yeast 
health and allow complete fermentation of 
corn solids up to 40 percent.” 
Deepak Kumar, a postdoctoral research 
associate in agricultural and biological 
engineering, says because the dry grind 
process uses a significant amount of water, 
using more solid material in the slurry—40 
percent as opposed to 30-35 percent—means 
less water going into the process. 
“When ethanol is produced, it is in a very 
dilute solution. You have a small amount of 
ethanol and a large amount of water,” Kumar 
said. “We cut down the water use by pushing 
high solids. When we reduce the amount of 
water, we also reduce the amount of energy 
required to remove the water.”
Singh believes this new research has the 
potential to improve the economics and 
process efficiencies and simplify the dry 
grind process. 
“By developing highly optimized technologies, 
we will benefit the entire dry grind industry,” 
he said.
 Singh and Kumar received the 2016 Bioenergy 
Society of Singapore (BESS) Achievement 
Award for their research, which was funded 
by the USDA. Their paper was published in 
the journal Biotechnology for Biofuels. 
NEW RESEARCH AT THE 
Integrated Bioprocessing Research 
Laboratory (IBRL) could significantly 
change ethanol production by lowering 
operating costs and simplifying the dry 
grind process.
 “There are currently more than 200 dry grind 
plants that are processing corn to produce 
ethanol,” said Vijay Singh, director of IBRL 
and a professor of agricultural and biological 
engineering (GEGC). “The dry grind process 
requires two different enzymes to convert 
corn starch to glucose, which is further 
fermented to ethanol by yeast.”
Singh says that process has been simplified 
by combined use and optimization of three 
new technologies. 
Amylase corn, which is a new corn developed 
by transgenic technology, produces one of 
these enzymes in the grain itself. A newly 
engineered “superior yeast” provides the 
second enzyme and ferments the glucose, 
according to Singh. 
“There is a high expression level of the first 
enzyme, α-amylase, in the new corn, so only 










Pictured: Field corn, used to make ethanol




The University of Illinois and the Partner 
Institute for Computational Biology in 
Shanghai collaborated to develop a computer 
model that can predict the yield of different crop 
cultivars in a multitude of planting conditions. 
The model, published in BioEnergy Research, 
depicts the growth of 3D plants, incorporating 
models of the biochemical and biophysical 
processes that underlie productivity.
Teaming up with the University of São Paulo in 
Brazil, researchers used the model to address a 
question for sugarcane producers: How much 
yield might be sacrificed to take advantage of a 
possible conservation planting technique?
According to author Stephen Long (BSD/
GEGC), Gutsgell Endowed Professor of Plant 
Biology and Crop Sciences, current sugarcane 
harvesters cut a single row at a time, which takes 
time and could lead to damage of crop stands. 
But their model found that this problem 
could be solved if the crop was planted in 
double rows with gaps in between. This costs 
about 10 percent of productivity compared to 
traditional row spacing.
“This model could be applied to other crops to 
predict optimal planting designs for specific 
environments,” said Yu Wang, a postdoctoral 
researcher who led the study. “It could also 
be used in reverse to predict the potential 
outcome for a field.”
The authors predict this model will be 
especially useful when robotic planting, 
which allows for more planting permutations, 
becomes more commonplace.
This research was supported by the IGB, 
the Bill & Melinda Gates Foundation via 
the Realizing Increased Photosynthetic 
Efficiency (RIPE) project, the EBI, and the 
Chinese Academy of Sciences.  
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RESEARCHERS HAVE DEVELOPED 
a technology that enables a smartphone to 
perform lab-grade medical diagnostic tests.
Costing only $550, the spectral transmission-
reflectance-intensity (TRI) Analyzer from the 
lab of Professor of Electrical and Computer 
Engineering, Brian Cunningham (ONC-
PM Theme Leader/MMG), attaches to a 
smartphone and analyzes patient blood, urine, 
or saliva samples as reliably as clinic-based 
instruments that cost thousands of dollars 
and require large, expensive instruments. 
“Our TRI Analyzer is like the Swiss Army 
knife of biosensing,” said Cunningham, 
also the Donald Biggar Willett Professor of 
Engineering and director of the Micro and 
Nanotechnology Lab at Illinois. “It’s capable 
of performing the three most common types 
of tests in medical diagnostics, so in practice, 
thousands of already-developed tests could be 
adapted to it.”
Their paper, published in Lab on a Chip, 
describes how their team used the TRI 
Analyzer to perform two commercially 
available tests—one that detects a biomarker 
associated with pre-term birth in pregnant 
women, and the PKU test for newborns 
that detects an enzyme essential for normal 
growth and development. Their test results 
were comparable to those acquired with 
clinic-grade spectrometer instrumentation. 
Among the many diagnostic tests that can 
be adapted to their point-of-care smartphone 
format is an enzyme-linked immunosorbent 
assay (ELISA), which detects and measures 
a variety of proteins and antibodies in blood 
and is commonly used for a wide range 
of health diagnostics tests. The system is 
capable of detecting the output of any test that 
uses a liquid that changes color, or a liquid 
that generates light output (such as from 
fluorescent dyes). 
“The TRI Analyzer is more of a portable 
laboratory than a specialized device,” said 
Kenny Long, an MD/PhD student and lead 
author of the research, which was supported 






The TRI Analyzer operates by converting the 
smartphone camera into a high-performance 
spectrometer. The Analyzer illuminates 
a sample fluid with the phone’s internal 
white LED flash or with an inexpensive 
external green laser diode. The light from 
the sample is collected in an optical fiber and 
guided through a diffraction grating into the 
phone’s rear-facing internal camera. These 
optical components are all arranged within a 
3D-printed plastic cradle. 
This technology can simultaneously measure 
multiple samples by using a microfluidic 
cartridge that slides through an opening in 
the back of the cradle. This ability to analyze 
multiple samples quickly and reliably makes 
the Analyzer suitable for patients who lack 
convenient access to a clinic or hospital with 
diagnostic test facilities or for patients with 
urgent health situations requiring rapid results. 
“Our Analyzer can scan many tests in a sequence 
by swiping the cartridge past the readout head, 
in a similar manner to the way magnetic strip 
credit cards are swiped,” Long said. 
In addition to its applications in health 
diagnostics, Cunningham said the TRI 
Analyzer can be used in applications for 
animal health, environmental monitoring, 
drug testing, manufacturing quality control 
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ONE OF HUMANKIND’S OLDEST INDUSTRIAL 
partners is yeast, a familiar microbe that enabled early 
societies to brew beer and leaven bread and empowers 
modern ones to synthesize biofuels and conduct key 
biomedical research. Despite this utility, our ability to 
explore and influence its genomic activity has lagged.
In an article in Nature Communications, Steven L. Miller 
Chair of Chemical and Biomolecular Engineering Huimin 
Zhao (BSD Theme Leader/MMG) and his coauthors 
described how their successful integration of several 
cutting-edge technologies—creation of standardized 
genetic components, implementation of customizable 
genome editing tools, and large-scale automation of 
molecular biology laboratory tasks—will enhance our 
ability to work with yeast. The results of their new 
method demonstrate its potential to produce valuable 
novel strains of yeast for industrial use.
“The goal of the work was really to develop 
a genome-scale engineering tool for yeast ... 
traditional metabolic engineering focused on 
just a few genes and the few existing genome-
scale engineering tools are only applicable to 
bacteria, not eukaryotic organisms like yeast,” 
said Zhao, who led the study. “A second 
innovation is the use of synthetic biology 
concepts, the modularization of the parts, and 
integration with a robotic system, so we can 
do it in high-throughput.”
The team focused on yeast in part because of 
its important modern-day applications; yeasts 
are used to convert the sugars of biomass 
feedstocks into biofuels such as ethanol and 
industrial chemicals such as lactic acid, or to 
break down organic pollutants.
The group took the first step toward their goal 
of a novel engineering strategy for yeast by 
creating what is known as a cDNA library: a 
collection of over 90 percent of the genes from 
the genome of baker’s yeast (Saccharomyces 
cerevisiae), arranged within a custom segment 
of DNA so that each gene will be, in one 
version, overactive within a yeast cell, and in 
a second version, reduced in activity.
Zhao and colleagues examined the ability of 
the CRISPR-Cas system, a set of molecules 
borrowed from a form of immune system 
in bacteria (CRISPR stands for Clustered 
Regularly Interspaced Short Palindromic 
Repeats, describing a feature of this system in 
bacterial genomes). This system allowed Zhao 
to make precise cuts in the yeast genome, into 
which the standardized genetic parts from 
their library could insert themselves.
“The first time we did this, in 2013, there 
was no CRISPR ... the best we could get was 
one percent of the cells modified in one run,” 
said Tong Si, an IGB Fellow. “We struggled 
a little on that, and when CRISPR came out, 
that worked. We got it to 70 percent [cells 
modified], so that was very important.”
With gene activity-modulating parts integrating 
into the genome with such high efficiency, the 
researchers were able to randomly generate 
many different strains of yeast, each with its 
own unique set of modifications. These strains 
were subjected to artificial selection processes 
to identify those that had desirable traits, such 
as the ability to survive exposure to reagents 
used in the biofuel production process.
The work, which was funded by the Roy 
J. Carver Charitable Trust, IGB, Defense 
Advanced Research Program Agency, and 
National Academies Keck Futures Initiative 
on Synthetic Biology, paves the way for similar 
approaches to broad-scale, automated genome 
engineering of other eukaryotic species.
 The goal of the work 
was really to develop 
a genome-scale 




Pictured: Yeast, single-celled fungi, have aided 
human technologies for thousands of years
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RESEARCHERS HAVE DEVELOPED 
a way to produce 3D images of live 
cattle embryos that could help 
determine embryo viability before 
in vitro fertilization in humans.
Infertility can be devastating for those who 
want children. Many seek treatment, and the 
cost of a single in vitro fertilization cycle can 
be $20,000, making it desirable to succeed 
in as few attempts as possible. Advanced 
knowledge regarding the health of embryos 
could help physicians select those that are 
most likely to lead to successful pregnancies.
The study, published in the journal Nature 
Communications, brought together electrical 
and computer engineering professor Gabriel 
Popescu and animal sciences professor 
Matthew Wheeler (RBTE) in a collaborative 
project through the Beckman Institute for 
Advanced Science and Technology at the 
University of Illinois. 
Their method, called gradient light interference 
microscopy, or GLIM, solves a challenge that 
other methods have struggled with—imaging 
thick, multicellular samples. 
“When looking at thick samples with other 
methods, your image becomes washed out 
due to the light bouncing off of all surfaces 
in the sample,” said graduate student Mikhail 
Kandel, the co-lead author of the study. “It is 
like looking into a cloud.”
GLIM can probe deep into thick samples 
by controlling the path length over which 
light travels through the specimen. The 
technique allows the researchers to produce 
images from multiple depths that are then 
composited into a single 3D image.
To demonstrate the new method, Popescu’s 
group joined forces with Wheeler and his 









“One of the holy grails of embryology is 
finding a way to determine which embryos 
are most viable,” Wheeler said. “Having 
a noninvasive way to correlate to embryo 
viability is key; before GLIM, we were taking 
more of an educated guess.”
Those educated guesses are made by 
examining factors like the color of fluids 
inside the embryonic cells and the timing of 
development, among others, but there is no 
universal marker for determining embryo 
health, Wheeler said.
“This method lets us see the whole picture, 
like a three-dimensional model of the entire 
embryo at one time,” said Tan Nguyen, the 
other co-lead author of the study.
Choosing the healthiest embryo is not the end 
of the story, though. “The ultimate test will be 
to prove that we have picked a healthy embryo 
and that it has gone on to develop a live 
calf,” said Marcello Rubessa, a postdoctoral 
researcher and co-author of the study.
“Illinois has been performing in vitro studies 
with cows since the 1950s,” Wheeler said. 
“Having the resources made available through 
(Popescu’s) research and the other resources 
at Beckman Institute have worked out to be a 
perfect-storm scenario.”
The team hopes to apply GLIM technology to 
human fertility research and treatment, as well 
as a range of different types of tissue research. 
Popescu plans to continue collaborating with 
other biomedical researchers and has already 
had success looking at thick samples of brain 
tissue in marine life for neuroscience studies. 
This research was supported by the NSF and 
the University of Illinois.
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From left: Marcello Rubessa, visiting scholar; Gabriel Popescu, Professor of Electrical and 
Computer Engineering and Bioengineering; and Matthew Wheeler, Professor of Animal 
Sciences. Cow embryo displayed on screen
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ANTIVIRAL DRUG RESISTANCE 
has long been a problem in modern 
society. As viruses evolve, they develop 
resistance to drugs used to treat 
infections, making treatments that rely 
on them less effective against diseases 
such as influenza.
Now, a group of researchers is approaching 
this problem with a new idea: what if antiviral 
drugs could evolve along with viruses to stop 
this resistance?
Christopher Brooke, Assistant Professor of 
Microbiology (IGOH), is part of a DARPA-
funded program called INTERfering and Co-
Evolving Prevention that hopes to achieve this.
The program’s goal is to develop a new class 
of biological therapeutics that can coevolve 
with viruses. That way, as the virus develops 
resistance to the therapeutic, the therapeutic 
would evolve and develop anti-resistance.
“It would be as dynamic as the pathogen, and 
so that would, ideally, eliminate or at least blunt 
the problem of evolved resistance,” Brooke said.
His team of five researchers will work on 
developing a therapeutic specifically for influenza. 
They hope to do this by creating therapeutics 
with a design based on viruses themselves. 
This idea is based on a natural phenomenon 
known as defective interference.
Under certain conditions, many viruses 
spontaneously produce virus mutants that are 
missing parts of their genome. These mutants, 
called defective interfering particles, compete 
with the virus and inhibit its ability to replicate.
Influenza produces these defective interfering 
particles regularly, and it has been hypothesized 
that they are detrimental to the virus.
“We’re not totally convinced that’s the case,” 
Brooke said.
He and his colleagues will instead make 
changes to the particles and see if they have a 
detrimental effect on the viral population.
“This program is basically trying to see if we 
can take that idea ... and engineer versions of 
these that can act as therapeutics,” Brooke said.
Using the advantages of mathematical modeling, 
which involves using mathematical concepts 
to describe real world situations, the team will 
decide which particles they want to test in the lab. 
They will work on identifying and characterizing 
every possible defective interfering particle 
that can be generated by influenza virus, and 
then analyze how these particles affect viral 
replication and transmission, how they affect 
the host cell, and other characteristics. 
Their end goal is to identify a particle known 
as a therapeutic interfering particle that could 
be introduced to an individual infected with 
influenza to decrease disease severity and limit 
forward transmission without promoting the 
evolution of resistance. 
Combating antiviral 
drug resistance with 
dynamic therapeutics
Regardless of whether this research will 
contribute to the ultimate goal of eradicating 
the influenza virus, the researchers expect 
to gain valuable information on how virus 
populations evolve, which is an area Brooke’s 
lab has already been exploring.  
There are many large-scale questions that 
Brooke and his lab hope to answer: Why 
is influenza so good at outrunning host 
immunity? Why are other viruses not? How 
does influenza’s genome affect how it evolves?  
Through this research, these questions could 
be addressed.
“We’re going to learn a huge amount about how 
influenza virus populations behave and evolve,” 
Brooke said. 
For Brooke, this research is a chance to continue 
studying viruses, which fascinate him.
“They’re super weird and they’re really 
interesting,” he said. “They’re always surprising 
us in terms of what we find them doing and 
how they work.”
The program’s goal 
is to develop a new 
class of biological 
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aims to serve both 
pets and people
Above: Timothy Fan, Professor of Veterinary Medicine, with his dog, Ember
In clinical trials, dogs tolerated all tested 
doses of cancer-drug-laden nanoparticles 
with no signs of toxicity. As in mice, the 
particles homed in on tumor sites, thanks 
to a coating of the drug pamidronate, which 
preferentially binds to degraded sites in bone. 
The nanoparticles also showed anti-cancer 
activity in mice and dogs.
The researchers report their results in the 
Proceedings of the National Academy of Sciences; 
the research was supported by the Morris 
Animal Foundation, the NIH and the NSF.
The dogs were companion animals with bone 
cancer that were submitted for the research trials 
by their owners, said veterinary clinical medicine 
professor Timothy Fan (ACPP/ONC-PM), 
who led the study with materials science and 
engineering professor Jianjun Cheng (RBTE).
“We wanted to see if we could evaluate 
these drug-delivery strategies, not only in a 
mouse model, but also at a scale that would 
mimic what a person would get,” Fan said. 
“The amount of nanoparticle that we ended 
up giving to these dogs was a thousand-
fold greater in quantity than what we would 
typically give a mouse.”
“Human bone tumors are much bigger 
than those of mice,” Cheng explained. 
“Nanoparticles must penetrate more deeply 
into larger tumors to be effective. That is 
why we must find animal models that are 
closer in scale to those of humans.”
Mice used in cancer research have other 
limitations. Researchers usually inject human 
or other tumor cells into their bodies to mimic 
human cancers, Fan said. They also are bred 
to have compromised immune systems, to 
prevent them from rejecting the tumors.
“That is one of the very clear drawbacks of 
using a mouse model,” Fan said. “It doesn’t 
recapitulate the normal immune system that 
we deal with every day in the person or in a dog.”
There also are limitations to working with 
dogs, he said. Dogs diagnosed with bone 
cancer often arrive at the clinic at a very 
advanced stage of the disease, whereas in 
humans, bone cancer is usually detected early 
because people complain about the pain and 
have it investigated.
“On the flip side of that, I would say that 
if you are able to demonstrate anti-cancer 
activity in a dog with very advanced disease, 
then it would be likely that you would have 
equivalent or better activity in people with a 
less advanced stage of the disease,” Fan said.
Fan is involved in several promising efforts 
to produce new cancer therapies while 
simultaneously elevating the care of pet 
animals. A drug developed in collaboration 
with chemistry professor Paul Hergenrother 
(ACPP Theme Leader) and used to successfully 
treat pet dogs with glioblastoma and other 
cancers, PAC-1, is now in clinical trials for 
use in human patients. Fan is partnering 
with the Morris Animal Foundation to run an 
innovative program that aims to test five new 
drugs in five years for less than $5 million.
   ...if you are able to 
demonstrate anti-cancer 
activity in a dog with very 
advanced disease, then it would 
be likely that you would have 
equivalent or better activity in 
people with a less advanced 
stage of the disease.
“
”
TEAMWORK BETWEEN VETERINARY MEDICINE AND ENGINEERING IS ENABLING 
researchers to test a bone cancer drug delivery system in animals bigger than the standard animal 
model, the mouse. They are using the experimental therapy to treat dogs—mammals closer in size 




In 2016, Glowacka, Kromdijk and Long 
reported in the journal Science that they can 
increase plant productivity by boosting levels 
of three proteins involved in photosynthesis. 
Their work confirmed that photosynthesis 
can be made more efficient to increase plant 
yield, a hypothesis some in the scientific 
community once doubted was possible. 
“The United Nations predicts that by 2050 
we’re going to need to produce about 70 
percent more food on the land we’re currently 
using,” Long said. “My attitude is that it is very 
important to have these new technologies on 
the shelf now because it can take 20 years 
before such inventions can reach farmer’s 
fields. If we don’t do it now, we won’t have 
this solution when we need it.”
Another innovative research endeavor to 
come out of the RIPE project came from the 
laboratories of Long and Professor of Civil and 
Environmental Engineering Praveen Kumar.
Their paper in Global Change Biology showed 
that soybean crops with fewer leaves have 
an increased yield. They attribute this yield 
boost to increased photosynthesis, decreased 
respiration, and diversion that would have 
been invested in more leaves than seeds. 
“We are trying to identify non-conventional 
techniques that can give us a quick boost 
in yield so that we can get closer to those 
predicted demands,” said first author and 
postdoctoral researcher Venkatraman 
Srinivasan. “Soybeans are one of the four 
major staple crops and also the most 
important vegetable protein source in the 
world. If we can increase the yield of soybeans, 
we can solve the problems of protein demand 
and food production at the same time.”
Through these discoveries and others that are 
likely to come, these scientists are on their 
way to making RIPE’s goals a reality.
SWEAT SNEAKS BENEATH KATARZYNA 
Glowacka’s sunglasses as she tiptoes around 
the carefully organized research plots. 
The tiny plants reach up to grasp the sun, 
creating a mosaic of greens and yellows as 
they grow and mature, a tapestry of hope 
for the researchers who have cared and 
cultivated them. 
Scientists have spent most of their summer in 
this one-acre field at the University of Illinois 
South Farms. More than three years of sweat, 
tears, and countless hours of work and research 
have been poured into the little sprouts. 
These plants are part of Realizing Increased 
Photosynthetic Efficiency (RIPE), an 
international research project with the aim of 
ensuring food security for millions of people, 
especially those in Sub-Saharan Africa and 
Southeast Asia. The project is funded by the Bill 
and Melinda Gates Foundation, the Foundation 
for Food and Agriculture Research, and the U.K. 
Department for International Development. 
The goal of this multi-million research project 
is to help increase the yields of crops—like 
rice and cassava—that these families already 
like and know how to grow. More farmers 
will produce more food to feed their families 
and sell for disposable income, increasing 
their access to medicine, education, and 
opportunities for the future.
RIPE has engineered these plants to 
photosynthesize more efficiently, enabling 
them to recover more quickly in fluctuating 
light conditions. 
Glowacka and postdoctoral researcher 
Johannes Kromdijk worked together for 
three years preparing their tobacco plants for 
this field trial. The plants represent years of 
photosynthesis research, including critical 
work by principal investigators Stephen 
Long, Gutgsell Endowed Professor of Plant 
Biology and Crop Sciences (BSD/GEGC), and 
University of California, Berkeley researcher 
Krishna Niyogi—an expert on the molecular 
processes underlying photoprotection.
RIPE research project fuels 
scientific breakthroughs




climate and crop 
yield
Researchers from the University of Illinois, 
the University of Birmingham, and other 
institutions around the world gathered at the 
IGB to discuss how to improve the capacity 
to predict the impact of climate change on 
future crop yield. 
“Our objective is to improve the ability of 
computer models to simulate the way 
crops are going to respond to rising carbon 
dioxide concentrations,” said co-organizer 
and Associate Professor of Plant Biology 
Andrew Leakey (GEGC). “That’s an important 
exercise because the models are used to make 
projections about how future climate will 
impact food and fuel availability.”
The workshop was supported by a seed grant 
from the Birmingham-Illinois Partnership 
for Discovery, Engagement and Education 
(BRIDGE). 
Leakey and his colleagues decided the best way 
to improve crop models was to bring together 
model developers with experimentalists. 
Modeling experts are particularly focused 
on representing and predicting the impact 
of rising carbon dioxide levels on crop yield. 
However, interactions between plants and 
their environment are incredibly complex. 
Gathering data on how crops are responding 
to a changing climate is also a significant 
experimental challenge. The University of 
Illinois and the University of Birmingham 
are among a handful of institutions with 
established experimental systems that can 
perform such Free-Air Carbon Dioxide 
Enrichment (FACE) experiments. 
The workshop’s organizers recognized the 
mutual need for better communication 
between modelers and experimentalists, 
and several collaborative relationships were 
launched. These are expected to lead to 
significant scientific and practical advances 
in our ability to understand crop responses to 
climate change. 
RIPE (is) an 
international research 
project with the goal of 
ensuring food security 





New book celebrates a 
union of Art and Science 
at Yellowstone
 
Mammoth Hot Springs in Yellowstone National 
Park represents a confluence of two seemingly 
contrasting views of the world. Its dramatic 
rock formations, diverse wildlife, and the flow 
of water for which it is named offer countless 
examples of natural beauty; yet scientists are 
drawn to these same features because of the 
unique opportunities they represent to better 
understand geological and biological processes.
A recently published volume created by 
Professor of Geology and Microbiology and 
Roy J. Carver Biotechnology Center Director 
Bruce Fouke (BCXT) and internationally 
known nature photographer Tom Murphy, 
The Art of Yellowstone Science: Mammoth Hot 
Springs as a Window on the Universe, uses a 
meticulously crafted collection of photographs 
to show these two views both stem from a 
common origin of curiosity and awe.
“In the pages of this book, Mammoth Hot 
Springs photographic art is melded with the 
natural sciences to search for common laws of 
nature through the power of observation and 
willingness to embrace the unexpected,” Fouke 
and Murphy wrote in a description on the 
book’s website, artofyellowstonescience.igb.
illinois.edu. “This new appreciation of nature 
at Mammoth is then applied to challenges 
faced by society, now and in the future.”
Pictured: Heart Spring, Yellowstone National Park. 
Photo by Tom Murphy
Geneticist Mary-Claire King 
gives IGB distinguished 
public lecture
Mary-Claire King, Professor of Genome 
Sciences and of Medicine at the University 
of Washington School of Medicine, spoke 
as part of the Spring IGB Distinguished 
Public Lecture series at the Alice Campbell 
Alumni Center. King studies the genetics and 
interaction of genetics and environmental 
influences on human conditions such as HIV, 
lupus, inherited deafness, and also breast and 
ovarian cancer.
King is well known for the discovery, made 
before the Human Genome Project had 
been fully developed, that a single gene on 
chromosome 17, later known as BRCA1, 
is responsible for many breast and ovarian 
cancers—as many as 5-10 percent of all cases of 
breast cancer may be hereditary. Her research 
has contributed to a greater understanding 
of how genetic information can aid cancer 
patients in making informed decisions about 
their present and future wellness.
King’s talk was titled “Genetic Analysis of 
Inherited Breast and Ovarian Cancer: From 
Gene Discovery to Precision Medicine and 
Public Health.” It explored the path her 
research took to lead to her seminal discovery, 
and how it has continued to expand since. The 
approach King developed to identify BRCA1 
has since proven valuable in the study of many 
other illnesses, and King has built on that 
research by identifying BRCA2 and extending 
her technique to other diseases and conditions.
 
IGB introduces Coursera 
community to genomic 
research
What is a genome? This question is the starting 
place for the IGB’s Massive Open Online 
Course (MOOC), “Genomics: Decoding the 
Universal Language of Life.” The course, 
available in both scheduled and self-paced 
formats on Coursera, contains six weeks of 
content and encompasses topics drawn from 
the IGB’s expansive research portfolio.
Students learn how genes work, why microbes 
play such an important role chemically, how 
DNA sequencing can be used to predict risk 
to health and wellness, and what differences 
exist in genetically modified plants. An honors 
track offers the opportunity to complete 
detailed writing projects that explore scientific 
and social topics in greater depth.
IGB Director and Swanlund Professor of 
Entomology Gene Robinson is the main 
instructor for the course. In addition, each 
module features several IGB researchers as 
guest instructors. These guest instructors 
cover both basic biological concepts and their 
connections to genomic research applications.
 
 
Gene Robinson and May 
Berenbaum featured on 
Reddit’s Ask Me Anything
 
IGB Director and Swanlund Chair in 
Entomology Gene Robinson, with Swanlund 
Chair and Head of Entomology May 
Berenbaum (GEGC/IGOH), were featured 
on Reddit’s Ask Me Anything (AMA). The 
popular series has included celebrities, 
scientists, authors, artists, U.S. presidents 
and more, and allows individuals to post 
questions online to be answered by the host.
An excerpt from their introduction to the 
online event read:
“We are two scientists who are fascinated by 
honey bees: their complex social lives, their 
collective ability to adapt to environmental 
challenges, their sophisticated cognitive 
abilities, and the vital role they play in 
agriculture and food production. We also 
share a common experimental approach: 
exploring the behaviors, life history, evolution, 
and health of honey bees and other insects by 
studying their genomes.”
Questions from participants ranged from 
the risks and benefits of pesticide use and 
threats to the health of pollinator populations, 
to the future possibilities of robot bees and 
details of bee social life and cognitive abilities. 
Berenbaum even responded to a request to 
brainstorm titles for a hypothetical sitcom 
featuring bees as characters: “‘Bee-witched’ 
doesn’t quite work ... How about ‘Bee’s 
Company’? ‘The Honey Mooners’? Hey, 
wait—I know! ‘The Golden Girls’!!”
Although questions can no longer be submitted, 








iGEM team claims bronze 
at annual Giant Jamboree 
in Boston
 
The University of Illinois International 
Genetically Engineered Machine (iGEM) 
team received a bronze medal at the annual 
iGEM Giant Jamboree last September 
for its development of a unique genetic 
component. Their designed promoter, 
a region of DNA that helps control the 
activity of a nearby gene, allows for greater 
predictability and control of that activity.
The iGEM Foundation is a non-profit 
organization devoted to promoting synthetic 
biology through education and competition 
within a collaborative community. High 
school and undergraduate teams design 
and construct genetically engineered 
machines—known as “BioBricks”—using 
standard biological parts. The submitted 
BioBricks are then added to iGEM’s 
Registry of Standard Biological Parts, which 
is available to researchers worldwide.
The 2016 team was the ninth from the 
University of Illinois to compete at the 
iGEM Giant Jamboree. The team of six 
undergraduate students—Caroline Blassick, 
Jonathan Chang, Viraat Goel, Augustine Koh, 
Mariam Saadah, and Hiba Shahid—received 
guidance from two faculty advisors: Assistant 
Professor of Biochemistry Auinash Kalsotra 
(GNDP/ONC-PM) and Assistant Professor of 
Bioengineering Ting Lu (BCXT/BSD/MME).
Funding for the 2016 team was provided in 
part by the IGB, the University of Illinois, 





 Pictured: iGEM Jamboree. 
Photo by iGEM Foundation and Justin Knight
Genome Day
GENOME DAY, held each year in mid-
fall, is an open-house style event at the 
Orpheum Children’s Science Museum where 
community members learn about DNA, 
genes, genomes, and evolution through a 
series of hands-on activities for all ages. In 
recent years, we have added multilingual 
support to the event, thanks to the members 
of the Illinois chapter of SACNAS (Society 
Devoted to Advancing Hispanics, Chicanos 
& Native Americans in Science) and the 
Chinese Students and Scholars Association. 
Art of Science
Our ART OF SCIENCE exhibits feature images 
from IGB’s research portfolio, enhanced 
to highlight the beauty and fascination 
encountered daily in scientific endeavors. 
The past year has continued to bring new 
developments to the program, from a new 
location for the opening of Art of Science 7.0 at 
Urbana’s [co][lab], to a plethora of new locations 
around the state for traveling exhibits, to the 
inception of an Art of Science zine.
 
Pollen Power
This year also brought the fifth annual 
POLLEN POWER camp, a week-long day 
camp offered each July to middle school 
girls with a passion for science. Funded 
in part by the NSF and the IGB, the camp 
is co-organized by plant biologists Lisa 
Ainsworth (GEGC) and Andrew Leakey 
(GEGC), IGB Core Facilities, and IGB 
Outreach staff. Female graduate students 
act as counselors for the plant science-
themed camp, which provides attendees 
with experience operating high-powered 
microscopes, printing 3D replicas of pollen 
grains, recording “news broadcasts” that 
discuss past and future climate, and, this year, 






The IGB strives to be a place “Where Science Meets Society.” 
Several annually recurring events comprise the cornerstone 
of our community engagement efforts. Throughout the 
academic year, they continued to stand out as moments of 
celebration and recognition of all that we gain through a 
shared appreciation of the science of genomes. 
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Slow motion waves of 
jumping genes in the 
human genome
Nature is full of parasites—organisms that 
flourish and proliferate at the expense of 
another species. Surprisingly, these same 
competing roles of parasite and host can be 
found in the microscopic molecular world of 
the cell. A new study by physicists Chi Xue 
and Nigel Goldenfeld (BCXT Theme Leader/
CGRH/GNDP) has demonstrated that 
dynamic elements within the human genome 
interact in a way that echoes populations of 
predators and prey.
The findings, published in Physical Review 
Letters and supported by NASA and the NSF, 
are an important step toward understanding 
the complex ways that genomes change over 
the lifetime of individual organisms, and 
how they evolve over generations. Goldenfeld 
and Xue embarked on this work because of 
their interest in transposons, small regions 
of DNA that can move from one part of the 
genome to another during the lifetime of 
a cell, a capability that has earned them the 
name “jumping genes.”
Some transposons cannot jump on their own, 
and instead can only steal spots from others. 
Xue and Goldenfeld’s results predicted that 
these competing populations of jumping 
genes are expected to oscillate. Too many 
“parasitic” elements, and their “hosts” start 
to suffer, and soon there are not enough to 
exploit. The parasites start to suffer, and their 
hosts make a comeback.
The model made the additional, surprising 
prediction that these oscillations occur over 
a timescale that is longer than the human 
lifespan—waves of transposons pushing 
and pulling at each other in slow motion 




treatments at odds: 
statins counter benefits of 
exercise
For those who suffer from high cholesterol 
levels, a multi-pronged approach is often 
recommended to improve health: diet 
modifications, exercise, and medications 
can all play a role. Unfortunately, these 
interventions may not always interact in 
desirable ways. New research by Associate 
Professor of Kinesiology and Community 
Health Marni Boppart (RBTE) added to a 
growing body of evidence that statins interfere 
with the beneficial outcomes of exercise.
In the study, which was funded by the 
University of Illinois Center for Health, 
Aging, and Disability, mice genetically 
disposed to have high cholesterol levels were 
treated with injections of either a statin, 
simvastatin (sometimes marketed as Zocor), 
or a neutral saline solution. Some mice from 
each group were offered access to a running 
wheel for exercise, while others were not.
Boppart and her colleagues found that while 
the mice treated with simvastatin did have 
lower cholesterol levels after two weeks 
than those treated with saline, they also had 
decreased grip strength—whether they had 
exercised on the running wheel or not. Statin-
treated mice with access to the running wheel 
had decreased muscle force and increased 
susceptibility to muscle fatigue compared 
with the saline-treated mice.
The mice that received simvastatin also 
gradually decreased their daily running 
distance over the two weeks of treatment. In 
a publication in PLoS One, the researchers 
suggested that these results could indicate 
that a history of exercise might not protect 
against these negative effects of statin 
treatment, which might become more 
extreme with more prolonged use. 
Two undergrads improve 
plant carbon-cycle models 
In the summer of 2012, two undergraduate 
students tackled a problem that plant ecology 
experts had overlooked for 30 years. 
The students demonstrated that different 
plant species vary in how they take in carbon 
dioxide and emit water through stomata, 
the pores in leaves. The data boosted the 
accuracy of mathematical models of carbon 
and water fluxes through plant leaves by 30 
to 60 percent.
In hindsight, the discovery might seem 
obvious, said plant biology professor Andrew 
Leakey (GEGC), who mentored the students 
and is a co-author of the study. 
Plant physiologists know there is diversity in 
the way plant stomata behave. But for the last 
30 years, the research community has failed 
to describe that diversity in mathematical 
models, Leakey said, mostly because few 
plant biologists know how to convert their 
insights into the mathematical equations that 
modelers need. 
Therefore, modelers have assumed that the 
stomata of all species behave in the same way. 
This oversimplification likely led to errors in 
model predictions. 
Kevin Wolz and Mark Abordo conducted the 
research when they were both undergraduate 
students. They collected leaves from 15 tree 
species and used gas exchange equipment 
to measure how the leaves responded to 
different light and atmospheric conditions.
Their study, published in Nature Ecology 
and Evolution, found a significant amount 
of variation in the way different tree species 
responded. Altering standard models with the 
new data dramatically improved the models’ 
accuracy.  The NSF and the EBI supported 
this research.
Research 
Slowing dangerous  
bacteria may be more 
effective than killing them 
Researchers have discovered a mechanism 
that allows bacteria of the same species to 
communicate when their survival is threatened. 
The study suggests it may be possible to 
slow dangerous infections by manipulating 
the messages these microbes send to each 
other, allowing the body to defeat an infection 
without causing the bacteria to develop 
resistance to the treatment.
The study, reported in the Proceedings of the 
National Academy of Sciences, builds on work 
conducted by other researchers at Illinois, 
including biochemist John Woodland 
Hastings, who died in 2014, and John Cronan 
(MMG), a professor and the head of the 
department of microbiology. 
“Bacteria are intelligent little organisms,” 
said biochemistry professor Satish Nair 
(MME/MMG), co-author of the study with 
postdoctoral researcher Shi-Hui Dong 
and other colleagues. “They can survive 
almost anywhere and quickly adapt to new 
conditions.” 
When bacteria compete with other microbes for 
scarce resources, the more successful group will 
produce a unique molecule—an antibiotic—to 
kill off the other species. Over time, however, 
bacteria have adapted to resist antibiotics. 
Nair and Dong’s NIH-funded study targeted 
the group signal that bacteria use to slow 
down growth, rather than the antibiotic 
signal to kill. Understanding how bacteria 
produce the signal paves the way for 
developing molecules that can disrupt the 
communication of specific bacteria, with little 
chance for drug resistance to develop. 
A new tool for genetically 
engineering the oldest 
branch of life
A study by G. William Arends Professor of 
Microbiology Bill Metcalf (MMG Theme 
Leader) and IGB Fellow Dipti Nayak (BCXT) 
has demonstrated the first successful use 
of CRISPR-Cas9 mediated genome editing 
in the third domain of life, Archaea. Their 
groundbreaking work, funded by the DOE 
and the Simons Foundation and reported 
in Proceedings of the National Academy of 
Sciences, has the potential to vastly accelerate 
future studies of these organisms.
“Under most circumstances our model 
archaeon, Methanosarcina acetivorans, has a 
doubling time of eight to ten hours ... what that 
means is that doing genetics, getting a mutant, 
can take months,” Nayak explained. “What 
CRISPR-Cas9 enables us to do, at a very basic 
level, is speed up the whole process.”
CRISPR, short for Clustered Regularly 
Interspaced Short Palindromic Repeats, is 
an immune defense system in archaea and 
bacteria that acts by identifying and storing 
short fragments of foreign DNA so that 
similar sequences can be quickly destroyed 
in the future, protecting the organism 
from viral invasion. Since its discovery, a 
version of this immune system—CRISPR-
Cas9—has been modified to edit genomes 
in the lab.
“[Methanogens are] a class of archaea that 
produce gigatons of this potent greenhouse 
gas [methane] every year, play a keystone 
role in the global carbon cycle, and therefore 
contribute significantly to global climate 
change,” Nayak said. By studying the 
genetics of Methanosarcina acetivorans and 
similar organisms, Nayak and Metcalf hope 
to gain not only a deeper understanding of 




IGB announces new 
Infection Genomics for 
One Health research 
theme
The IGB announced its newest research theme, 
Infection Genomics for One Health (IGOH).
The theme will study how infection is 
transmitted, how new diseases emerge, and 
how antimicrobial resistance plays a role 
in the infection process through the lens 
of the interaction of genes, genomes and 
microbial organisms, within both human 
and agricultural ecosystems. 
The theme will incorporate the concept of 
One Health, which recognizes that human 
health is fundamentally dependent on the 
wellbeing of the surrounding ecosystem, 
whether natural or industrial.
Microbes form hidden linkages that connect 
these ecosystems and shape their health and 
disease. Predictive models for the movement 
of genes, genomes, and microbes among 
these interconnected microbial ecosystems 
are desperately needed to develop strategies 
to address urgent and critical threats to 
human health.
IGOH’s aim is to develop a broad and predic-
tive framework for infection biology that will 
directly address these challenges. 
Rachel Whitaker, Associate Professor of 
Microbiology, will serve as the theme’s 
leader. The theme’s faculty members include 
researchers from areas such as entomology, 
animal biology, microbiology, computer 
science and bioengineering, and more. 
“We have seen increasing evidence recently 
of the risk of epidemic outbreaks, and of the 
impact of the environment on the health and 
wellbeing of its inhabitants,” said IGB Director 
and Swanlund Professor of Entomology 
Gene Robinson. “To determine the changes 
that microbial communities undergo and 
the dynamics that result has immense 
potential to add important new insights to 
our understanding of critical human and 
environmental health challenges.” 
Research to investigate oil 
field biosouring with new 
technology 
A new IGB research project seeks to solve a 
$90 billion global problem in the oil industry 
while making oil drilling less harmful to the 
environment.    
Bruce Fouke (BCXT), Professor in the 
departments of Geology and Microbiology and 
director of the Roy J. Carver Biotechnology 
Center, was awarded a three-year grant from 
the Dow Chemical Company to study a 
process known as oil field biosouring. 
Co-investigators include IGB affiliate Professor 
Charles Werth (BCXT) at the University of 
Texas at Austin, and Robert Sanford, Research 
Associate Professor in Geology at Illinois.
Biosouring results from seawater being 
pumped deep underground in order to 
maximize the amount of oil extracted. 
Seawater contains a chemical called sulfate. 
When bacteria in the ground ingest sulfate, 
they create sulfide, a highly corrosive 
chemical. This reduction, from sulfate to 
sulfide, is known as microbial biosouring.
Sulfide’s corrosive nature creates the single 
largest maintenance expense for oil companies: 
replacement of underground oil field pipes and 
plumbing systems. 
Fouke and his IGB research colleagues plan 
to better understand how biosouring happens 
and how to stop it by using a technology they 
developed called the GeoBioCell. 
The GeoBioCell is an experimental micro-
fluidics test bed that can be used to track the 
interactions between water, rock, microbes, oil 
and gas in a controlled environment. 
By recreating biosouring conditions within 
the GeoBioCell, researchers will be able to 
test different scenarios to try and reduce or 
stop the process and understand how oil and 
gas is produced while better protecting the 
environment. 
Woese undergraduate 
research scholar  
embraces challenges
Since his freshman year of college, Yuhao 
Min has been passionate about research.
He got a chance to pursue what he loves 
through IGB’s Carl R. Woese Undergraduate 
Research Scholarship. The scholarship 
awards funding to undergraduate students so 
they can pursue interdisciplinary research at 
IGB over the summer.
As the 2017 recipient, Min pursued research 
with Huimin Zhao (BSD Theme Leader/
MMG), Steven L. Miller Chair in Chemical 
Engineering, and Wilfred van der Donk 
(MMG), Richard E. Heckert Endowed Chair 
in Chemistry.
Min’s collaborative research project is focused on 
engineering a peptidic anticancer compound, 
nisin, a peptide that has been used as a food 
preservative but also has a broad antimicrobial 
spectrum. It has been shown to be a potential 
therapeutic for treating cancers such as head 
and neck squamous cell carcinoma.
“We want to optimize this peptide, using the 
tools we developed before, to make it more 
potent, more stable, and more specific toward 
the cancer,” Min said.
As a double major in chemistry and molec-
ular and cellular biology, Min finds himself 
fascinated by the interdisciplinary approach-
es that his research has taken.
“I find when you look into a problem from 
another perspective, you can always find some 
other solution to the specific problems,” he said.
News 
IGB receives Grand 
Challenges Explorations 
grant
The IGB was awarded funding from Grand 
Challenges Explorations, an initiative fund-
ed by the Bill & Melinda Gates Foundation, 
which supports innovative thinkers world-
wide to explore ideas that can break the mold 
in how we solve persistent global health and 
development challenges. 
Patrick Degnan (CGRH/IGOH/MME), As-
sistant Professor of Microbiology, will pursue 
an innovative global health and development 
research project titled “CRISPR capture: sur-
veillance of AMR in mobile microbiomes.”
To receive funding, Degnan and other 
Grand Challenges Explorations winners 
demonstrated a bold idea in one of six critical 
global health and development topic areas.
Degnan, in collaboration with Professor 
of Anthropology Rebecca Stumpf (BCXT/
CGRH) and Associate Professor of 
Microbiology Rachel Whitaker (IGOH 
Theme Leader/BCXT), will work to better 
understand how antimicrobial resistance 
(AMR) spreads in different environments 
by examining the flow of AMR genes in 
microorganisms between adjacent human 
and chimpanzee populations in eastern 
Africa. Their research will eventually allow for 
more targeted measures to slow the spread of 
AMR in human and agricultural pathogens.
“We can’t just focus on human pathogens 
anymore. We can’t just focus on animal 
pathogens or plant pathogens, but we have to 
think about infection biology as a whole,” said 
Degnan. “To be able to understand how to 
stop transmission, we need to find out what 
transmission is, and our research is really 
geared towards that.”
New center will apply 
computing to large-scale 
genomic problems
The University of Illinois is leading a new 
center that seeks to develop a new platform 
for generating, interpreting, and applying 
genomic data for a wide variety of applications. 
Working with colleagues at Mayo Clinic, 
researchers in the Center for Computational 
Biotechnology and Genomic Medicine 
(CCBGM) will advance pressing societal 
issues, such as enabling patient-specific 
treatment of cancer and other diseases and 
supporting humanity’s growing need for food 
by improving the efficiency of agriculture.
The center is funded for five years through the 
National Science Foundation’s Industry/Uni-
versity Cooperative Research Center program. 
CCBGM will seek to address challenges in 
computational genomics by developing new 
computer platforms that can more efficiently 
scale to the rapidly growing volume, velocity, 
and variety of genomic data. 
Researchers also will work to enhance the 
capability of computers to evaluate data and 
provide actionable intelligence for treatment. 
They will design new architectures that 
can optimize genomic analysis workflows, 
providing unprecedented speed and energy 
efficiency while preserving the accuracy of 
the analytics.
The center is part of CompGen, an initiative 
between the IGB and the Coordinated Science 
Laboratory. Through CompGen, researchers 
have built a new instrument that will serve as 
the computational engine of the center. 
“We are very excited to work with some of the 
leading companies in computing technology, 
pharmaceuticals, and agricultural biotechnology 
to create the computational breakthroughs 
that are necessary to realize the fruits of the 
genomic revolution,” said Gene Robinson, 
Swanlund Professor of Entomology and Director 
of the IGB. 
IGB creates partnership 
with ZEISS labs@location 
program
An agreement between the IGB and ZEISS 
has named the Core Facilities at IGB an 
official ZEISS labs@location Partner. 
The model facility will allow researchers from 
around the U.S. to test-drive new instruments 
in the IGB’s Core Facilities microscopy suite. 
This partnership represents the first North 
American location of the ZEISS labs@
location partner program, already in use 
across Europe.
The agreement will allow IGB and Illinois 
researchers access to select cutting-edge 
technologies immediately following—or in 
some cases before—their broad release. New 
instruments, on loan from ZEISS, will cycle 
through Core Facilities and be available to all 
users during that time. 
In addition, the agreement provides for 
training taught by ZEISS personnel at the IGB 
that will better position Core Facilities staff 
and researchers to best utilize new equipment. 
ZEISS instrument specialists will provide 
valuable instruction and instrument demos to 
Illinois and visiting scientists, as well as assist 
in training the IGB Core Facilities staff to 
provide similar instruction themselves.
Glenn Fried, director of IGB Core Facilities, an-
ticipates that one of the first new instruments 
under the agreement will be a ZEISS Celldiscov-
erer 7, a new automated microscopy platform for 
high throughput live cell imaging that allows for 
sharper, more accurate images.
“This is a really exciting thing for the Core 
and for everyone who uses our instruments,” 
Fried said. “Researchers will have access 
to the newest technology—like ZEISS 
Celldiscoverer—long before they would if we 





Andrew Alleyne, Professor 
of Mechanical Science & 
Engineering (BSD) was awarded 
the Society of Women Engineers 
(SWE) Advocating Women in 
Engineering Award.
Rashid Bashir, Bioengineering 
Professor (RBTE) received a 
Campus Award for Excellence in 
Faculty Leadership.
Girish Chowdhary, Assistant 
Professor of Agricultural and 
Biological Engineering (GEGC) 
was elected to the grade of 
Associate Fellow, Class of 2018 
in the American Institute of 
Aeronautics and Astronautics 
(AIAA).
John Cronan, Professor and 
Head of Microbiology and 
Professor of Biochemistry 
(MMG) was elected to the 
National Academy of Sciences.
John Gerlt, Gutgsell Professor 
of Biochemistry (MMG) was 
awarded the 2017 Gordon 
Hammes Lectureship.
Paul Hergenrother, Professor of 
Chemistry (ACPP Theme Leader) 
received the Arthur C. Cope 
Scholar Award by the American 
Chemistry Society (ACS).
Princess Imoukhuede, 
Assistant Professor of 
Bioengineering (RBTE) 
received a National Science 
Foundation Faculty Early Career 
Development Program CAREER 
Award.
Thomas Kehl-Fie, Assistant 
Professor of Microbiology (MMG) 
was named a 2017 Vallee Scholar 
by the Vallee Foundation.
Hyunjoon Kong, Professor and 
Centennial Scholar in Chemical 
and Biomolecular Engineering 
(RBTE) was named an American 
Institute for Medical and 
Biological Engineering (AIMBE) 
Fellow.
Stephen Long, Gutgsell 
Endowed Professor of Crop 
Sciences and Plant Biology 
(GEGC), was appointed to the 
Newton Abraham Visiting 
Professorship in the Department 
of Plant Sciences at the 
University of Oxford, United 
Kingdom.
Zeynep Madak-Erdogan, 
Assistant Professor of Nutrition 
(ONC-PM) was awarded a 2017-
18 NCSA Faculty Fellowship.
Ruby Mendenhall, Associate 
Professor in Sociology, African 
American Studies, Urban and 
Regional Planning, and Social 
Work (CGRH/GNDP) received 
the Black Metropolis Research 
Consortium Fellowship, 
sponsored by the Melon 
Foundation, and was awarded 
a 2017-18 NCSA Faculty 
Fellowship.
Jeffrey Moore, Murchison-
Mallory Professor of Chemistry 
and Professor of Materials 
Science and Engineering (BSD) 
was elected to the National 
Academy of Sciences.
Donald Ort, Robert Emerson 
Professor of Plant Biology, 
USDA/ARS Photosynthesis 
Research Unit and Adjunct 
Professor of Crop Sciences 
(GEGC Theme Leader) was 
elected to the National Academy 
of Sciences.
Gene Robinson (Director) was 
invited to serve as a member 
of the Convergence Advisory 
Group of the National Academies 
of Sciences, Engineering, and 
Medicine.
Rebecca Stumpf, Associate 
Professor of Anthropology 
(BCXT/CGRH/IGOH) received a 
Campus Award for Excellence in 
Undergraduate Teaching.
Andrew Suarez, Professor of 
Animal Biology (GNDP) received 
a Campus Award for Excellence 
in Undergraduate Teaching.
Tandy Warnow, Founder 
Professor of Bioengineering 
and Computer Science (BCXT, 
CGRH/IGOH) was elected a 
2017 Fellow of the International 
Society for Computational 
Biology (ISCB).
Huimin Zhao, Steven L. 
Miller Chair in Chemical and 
Biomolecular Engineering (BSD 
Theme Leader/MMG), was 
recognized by the Society for 
Biological Engineering (SBE) 
with the 2017 Biotechnology 
Progress Award for Excellence 




National Science Foundation 
“Collaborative Research:  REU 
Site:  Phenotypic Plasticity 




National Institutes of Health 
“Development of a Liposomal 




University of Illinois at Chicago/
Department of Defense 
“Histatin Peptides as a Treatment 
for Ocular Surface Injury and 




University of Illinois at Chicago/
National Institutes of Health 







National Science Foundation 
“Computing and Genomics—an 




Mayo Clinic & Illinois Alliance 
(Mayo Clinic Fellowship) 
“Mayo Clinic and Illinois Alliance 





“Metabolic Engineering of 
Carbon Pathways to Enhance 
Yield of Root and Tuber Crops”
Ripan Malhi 
National Institutes of Health 
“Expanding the Impact of the 
Summer Internship for Native 




U.S. Department of Agriculture 
“Congress on Gastrointestinal 






“CRISPR Capture: Surveillance 
of AMR Amongst the Mobile 
Microbial Dark Matter”
Rachel Whitaker 
Cystic Fibrosis Foundation 
“Individualized Early Detection 
of High-risk Pseudomonas 










“Microbial Forensics to Track 
Zoonotic, Epizoonotic, and 
Anthropogenic Routes of 
Antimicrobial Resistance in 
Western Uganda”
Wen-Tso Liu 
British Petroleum - University of 
CA, Berkeley 
“Evaluating Co-digestion as 
a Method of Waste Activated 
Sludge Minimization at Purified 




British Petroleum - University of 
CA, Berkeley 
“Soil Analysis in Sugar Cane”
Mayandi Sivaguru 
Mead Johnson & Company LLC 
“Imaging Based Characterization 




National Institutes of Health 
“Discovery of Novel Natural 
Products via Characterization 




National Institutes of Health 
“Child Trauma and the 
Development of Neural Systems 
Underlying Emotion Regulation”
Bruce Fouke 
Dow Chemical Company 
“Controlling Hydrocarbon 
Formation Damage to Enhance 
Souring Control and Energy 
Production”
William Metcalf 
Microbial Pharmaceuticals. Inc. 
“A Metabologenomics Platform 
for Large-Scale, High-Throughput 
Natural Product Discovery”
Rachel Whitaker 
Paul G. Allen Family Foundation 
“Microbial Evolution through 





National Institutes of Health 
“Epigenomic Predictors of PTSD 
and Traumatic Stress in an 
African American Cohort”
Lisa Stubbs 
National Institutes of Health 





Iwona Jasiuk  
Gregory Underhill 
Matthew Wheeler 
National Science Foundation 
“MRI: Acquisition of a JD 
Bioprinting System to Generate 
Composite Biomaterials for 
Regenerative Medicine”
John Gerlt 
National Institutes of Health 
“Novel Strategies for the 




Department of Energy 
“Genome-scale Design and 
Engineering of Non-model Yeast 






Department of Energy 
“Building on Success in Systems 
Design of High Yielding Low-




Pictured: iGEM members and sophomores in bioengineering, Rachel Walker and Maggie Barbero, work in IGB
Give to the IGB
IGB Annual Fund 
Gifts to the IGB help us to foster the collaborative 
environment that we believe is vital for progress 
in genomic research. Philanthropy helps us 
create opportunities for building strong working 
relationships with intelligent, talented researchers 
from our own campus, and from across the world. It 
allows us to provide grants for promising, but risky, 
research projects that more traditional funding 
agencies might be hesitant to support. Research 
needs evolve quickly and unrestricted gifts to the 
IGB Annual Fund permit us to optimize funds by 
allocating them for the projects that need them most. 
Carl R. Woese  
Research Fund 
Donations may be made to the Carl R. Woese 
Research Fund to support research on evolution, 
systems biology, and ecosystem dynamics at the 
IGB. Professor Woese approved this fund in his 
name to help the next generation of scientists 
and to recognize his discoveries and work that 
spanned nearly half a century at the University of 
Illinois at Urbana-Champaign.
iGEM Undergraduate  
Team
The IGB hosts a team of undergraduates from 
multiple departments to participate in the In-
ternational Genetically Engineered Machine 
(iGEM) competition. This opportunity provides 
students the development of open community 
and collaboration for the advancement of syn-
thetic biology. Funds for the iGEM team will 
give undergraduates the chance to present their 
research to an international audience in Boston.
Stay Connected with the IGB
Stay connected to news, events, and program 
information at the Carl R. Woese Institute for 
Genomic Biology. By joining our mailing list, 
you’ll receive our e-newsletter, publications, 
and details about seminars, workshops, and 










The vision of scientific research is limited by the pace of innovation. New technologies let us see the physical world more clearly, in greater detail, in finer 
scales of space and time. Genomic research, around which the IGB is focused, is particularly tied to advancing technologies. 
To continue our record of high-quality research, we need to maintain our position at the forefront of the field. We move past traditional divisions between 
disciplines of study by constructing a network of collaborations. With your help, we will continue to forge a path toward our vision of a better world. 
